These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 664050)

  • 1. [Fibrin-fragment D-protector equilibrium system. Quantitative determination of protector activity].
    Ugarova TP; Belitser VA
    Ukr Biokhim Zh (1978); 1978; 50(3):357-63. PubMed ID: 664050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biologically active low-molecular fragments of fibrinogen molecule].
    Musialkivs'ka AO; Platonova TM; Radavs'kiĭ IuL
    Ukr Biokhim Zh; 1977; 49(3):89-93. PubMed ID: 888231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative determination of protector activity of fibrinogen tryptic hydrolysates].
    Musialkivs'ka AO; Pozdniakova TM; Platonova TM; Khomenko VM
    Ukr Biokhim Zh; 1977; 49(4):118-23. PubMed ID: 19861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies in the fibrinogen molecule D fragment inactivation protecting fragment].
    Uharova TP; Smekhova KO; Musjalkivs'ka AO
    Ukr Biokhim Zh; 1977; 49(5):60-3. PubMed ID: 919058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation of the fragment D dimer from stabilized fibrin and a study of its antipolymerization action].
    Musialkovskaia AA; Khodorova EL; Pozdniakova TM
    Ukr Biokhim Zh; 1976; 48(2):139-43. PubMed ID: 941302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophoretic fractions and NH2-terminal amino acids of high-molecular tryptic fragments of fibrinogen and fibrin].
    Lugovskoĭ EV; Pozdniakova TM; Varetskaia TV; Derzskaia SG; Tolstykh VM
    Ukr Biokhim Zh; 1976; 48(6):743-9. PubMed ID: 1014141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Equilibrium system consisting of soluble forms of fibrin and the specific anticoagulant D fragment of the firbinogen molecule].
    Smekhova KO; Ugarova TP; Pozdniakova TM; Belitser VO
    Ukr Biokhim Zh; 1977; 49(6):5-11. PubMed ID: 22149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.
    Spraggon G; Everse SJ; Doolittle RF
    Nature; 1997 Oct; 389(6650):455-62. PubMed ID: 9333233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphism of fibrin equilibrium oligomers in the presence of fragment D].
    Gershkovich KB; Rozenfel'd MA
    Mol Biol (Mosk); 1989; 23(2):596-604. PubMed ID: 2770733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic activity of fibrin degradation products is located in fibrin fragment E.
    Thompson WD; Smith EB; Stirk CM; Marshall FI; Stout AJ; Kocchar A
    J Pathol; 1992 Sep; 168(1):47-53. PubMed ID: 1280677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrin fragment beta 15-118. Inhibitory and complex-forming properties].
    Lugovskoĭ EV; Chudnovets VS; Makogonenko EM; Derzskaia SG; Gogolinskaia GK; Mikhalovskaia LI; Komissarenko SV
    Ukr Biokhim Zh (1978); 1995; 67(4):57-64. PubMed ID: 8553474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticlotting activity of fragment D from fibrinogen and fibrin and its dependence on calcium presence when fragments are obtained from fibrinogen].
    Tolstikh VM; Varets'ka TV
    Ukr Biokhim Zh; 1976; 48(1):116-21. PubMed ID: 1258156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the fragment D-fibrin monomer complex formation by salting-out fractionation].
    Pozdniakova TM; Rybachuk VN; Vovk Ev
    Biokhimiia; 1982 Jun; 47(6):971-6. PubMed ID: 7115809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [alphaC domains of fibrinogen molecules as the structures accelerating fibrin assembly].
    Medved' LV; Gorkun OV; Maniakov VF; Belitser VA
    Mol Biol (Mosk); 1986; 20(2):461-70. PubMed ID: 3702870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble complexes of the NH2-terminal disulfide knot of fibrin with molecules containing D domains].
    Pozdniakova TM; Rybachuk VN; Vovk EV
    Ukr Biokhim Zh (1978); 1983; 55(6):614-21. PubMed ID: 6659078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fragment of the fibrinogen molecule with properties of fibrin assembly protector].
    Musialkovskaia AA; Ugarova TP; Pozdniakova TP; Belitser VA
    Dokl Akad Nauk SSSR; 1978; 240(3):748-51. PubMed ID: 668488
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interaction of fibrinogen and fibrin with protamine sulfate].
    Mikhalovskaia LI; Varetskaia TV; Belitser VA
    Ukr Biokhim Zh (1978); 1988; 60(4):3-9. PubMed ID: 3188253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.